Navigation Links
Leading Scientists to Debate Views on Rejuvenation Biotechnologies
Date:4/17/2012

MOUNTAIN VIEW, Calif., April 17, 2012 /PRNewswire-USNewswire/ -- The following is being released by SENS Foundation:

The Oxford University Scientific Society is hosting a debate on Wednesday, 25th April, 2012. The debate will begin at 7 p.m. local time (11 a.m. Pacific, 2 p.m. Eastern) in the University of Oxford's Sheldonian Theatre; doors open 45 minutes earlier.

Dr. Aubrey de Grey will propose the motion "This house wants to defeat ageing entirely" and Professor Colin Blakemore will be opposing.  The debate will be chaired and moderated by Professor Sir Richard Peto. This debate will address whether it is feasible and appropriate to consider ageing as a target of decisive medical intervention, raising the possibility of substantial extension of human lifespan. 

Aubrey de Grey is currently Chief Science Officer of SENS Foundation, a biomedical research charity that aims to develop, promote, and ensure widespread access to rejuvenation biotechnologies that address the diseases and disabilities of ageing. SENS Foundation aims to bring ageing under comprehensive medical control. Its research agenda consists of the application of regenerative medicine to ageing - not merely slowing the ageing clock, but resetting it to early adulthood. To learn more about SENS Foundation, please visit sens.org.



Colin Blakemore is Professor of Neuroscience at the University of Oxford Nuffield Department of Clinical Neurosciences. He is an expert in vision, development of the brain and neurodegenerative disease. He is active in communication of science and is president and adviser to several charities concerned with brain disorders. Prof. Blakemore was formerly Chief Executive of the Medical Research Council, the UK's largest public funder of biomedical research. 


Along with presentations and discussion from Aubrey de Grey and Colin Blakemore, the debate will provide an opportunity for questions from the audience.  



The entire event will be moderated by Professor Sir Richard Peto, Professor of Medical Statistics and Epidemiology at the University of Oxford, and an expert on the hazards of smoking and benefits of stopping. 
The Oxford University Scientific Society is a student society that aims to disseminate science research and to promote scientific discussions.

For more information on the debate, please visit the OUSS website at http://users.ox.ac.uk/~science/.

For background information on the presenters, please visit the following links:
 


http://www.sens.org/users/aubrey-de-grey
http://www.dpag.ox.ac.uk/academic_staff/colin_blakemore/


'/>"/>
SOURCE SENS Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
2. Urologists Debunk Misleading, Grossly Inaccurate Prostate Cancer Biopsy Study
3. Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012
4. Floridas Leading Fertility Center Announces Successful Baby Delivery via Egg Freezing
5. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
6. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
7. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System
8. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
9. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
10. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
11. BioSpace Spotlights Leading Life Science Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... innovative medical technologies, services and solutions to the healthcare market. The company's primary ... various distribution, manufacturing, sales and marketing strategies that are necessary to help companies ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):